iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy

Recent advances in induced pluripotent stem cell (iPSC) technology and directed differentiation of iPSCs into cardiomyocytes (iPSC-CMs) make it possible to model genetic heart disease in vitro. We apply CRISPR/Cas9 genome editing technology to introduce three RBM20 mutations in iPSCs and differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Briganti, Francesca, Sun, Han, Wei, Wu, Wu, Jingyan, Zhu, Chenchen, Liss, Martin, Karakikes, Ioannis, Rego, Shannon, Cipriano, Andrea, Snyder, Michael, Meder, Benjamin, Xu, Zhenyu, Millat, Gilles, Gotthardt, Michael, Mercola, Mark, Steinmetz, Lars M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168789/
https://www.ncbi.nlm.nih.gov/pubmed/32905764
http://dx.doi.org/10.1016/j.celrep.2020.108117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168789/
https://www.ncbi.nlm.nih.gov/pubmed/32905764
http://dx.doi.org/10.1016/j.celrep.2020.108117

Ejemplares similares